# Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery

Study · id `cardio:ct-nct03280745` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03280745](<https://clinicaltrials.gov/study/NCT03280745>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03280745

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

## Technical summary

Registry record NCT03280745. Randomized; quadruple masking; primary purpose prevention. Start 2018-02-27 (actual); primary completion 2019-05-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 165 participants (enrolled count; ClinicalTrials.gov record NCT03280745, source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)
- Started: 2018-02-27 (actual) (ClinicalTrials.gov record NCT03280745, source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)
- Primary completion: 2019-05-27 (actual) (ClinicalTrials.gov record NCT03280745, source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)
- Completion: 2019-09-30 (actual) (ClinicalTrials.gov record NCT03280745, source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT03280745, source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03280745-2020-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
- Acronym: HERACLES
- Condition: Cardiovascular Diseases
- Condition: Valvular Heart Disease
- Intervention (Drug): Hypertonic saline
- Intervention (Drug): 0.9% saline
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)

## Provenance

Content hash: 00599ef01ba10b2837e0eb229683286a502ae154ca8f867f1e283858a3a2807c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
